Supplementary Table S8 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial
Authors:
- Mattia ReditiMRMattia Rediti
- Danai FimereliDFDanai Fimereli
- Magdalena MilevaMMMagdalena Mileva
- Zéna WimanaZWZéna Wimana
- David VenetDVDavid Venet
- Patrick FlamenPFPatrick Flamen
- Thomas GuiotTGThomas Guiot
- Elisabeth G.E. de VriesEVElisabeth G.E. de Vries
- Carolien P. SchröderCSCarolien P. Schröder
- Catharina Willemien Menke-Van der Houven van OordtCOCatharina Willemien Menke-Van der Houven van Oordt
- Marion MaetensMMMarion Maetens
- Samira MajjajSMSamira Majjaj
Open Access
- 6 January 2025
- other
- Published by American Association for Cancer Research (AACR)